InflaRx (IFRX) Cash from Financing Activities (2016 - 2026)
InflaRx (IFRX) recorded Cash from Financing Activities of $225.39 million in Q2 2026, compared with -$112,978 a year earlier.
Powered by 
Analysis
InflaRx (IFRX) Cash from Financing Activities (2016 - 2026) Analysis & Trends
On a TTM basis, InflaRx's Cash from Financing Activities came in at $38.78 trillion as of Jun 30, 2026; for FY2025, it came in at $37.64 trillion.
- Annual Cash from Financing Activities has a five-year compound annual growth rate of 1929.4% (FY2020 to FY2025).
- Across earlier years, Cash from Financing Activities came in at $412.95 billion in FY2024 (-99.3%), $57.01 trillion in FY2023, $1.98 trillion in FY2022 (-97.2%) and $70.44 trillion in FY2021.
- Quarterly Cash from Financing Activities has ranged from -$115.6 million in Q2 2024 to $70.44 trillion in Q4 2021 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$87.44 million (Q1 2026), $38.78 trillion (Q4 2025) and -$99,315 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | -8.78 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | -3.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -3.66 Bn |
| 10 | InflaRx | 104.63 Mn | -228.98 Mn | 2.74 Mn | 225.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 225.39 Mn |
| Mar 31, 2026 | -87.44 Mn |
| Dec 31, 2025 | 7.56 Mn |
| Sep 30, 2025 | -99,314.74 |
| Jun 30, 2025 | -112,977.50 |
| Mar 31, 2025 | 28.41 Mn |
| Dec 31, 2024 | 310.46 Mn |
| Sep 30, 2024 | -318.43 Mn |
| Jun 30, 2024 | 92.09 Mn |
| Mar 31, 2024 | -93.11 Mn |
| Dec 31, 2023 | -102,107.77 |
| Sep 30, 2023 | -102,637.75 |
| Jun 30, 2023 | 25.02 Mn |
| Mar 31, 2023 | 32.42 Mn |
| Dec 31, 2022 | 280.60 Mn |
| Sep 30, 2022 | -275.17 Mn |
| Jun 30, 2022 | 96.70 Mn |
| Mar 31, 2022 | -101.91 Mn |
| Dec 31, 2021 | -43,685.96 |
| Sep 30, 2021 | -104,343.34 |
API Access
InflaRx Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IFRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "IFRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IFRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();